David G. McVey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David G. McVey has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
- Shu Ye
Division of Basic Medicine, Shantou University Medical College, Shantou 515041, China
13 shared publications - Tom R. Webb
Department of Cardiovascular Sciences, Leicester British Heart Foundation Centre of Research Excellence and National Institute for Health and Care Research Leicester Biomedical Research Centre, University of Leicester (R.M.D., P.S.B., C.P.N., A.P.B., N.J.S., T.R.W.).
7 shared publications Nilesh J. Samani
Division of Cardiovascular Sciences, University of Leicester, Leicester, UK
5 shared publications- Charles Ugochukwu Solomon
Division of Cardiovascular Sciences, University of Leicester, Leicester LE3 9QP, UK
4 shared publications Peng Gong
Division of Cardiovascular Sciences, University of Leicester, Leicester, UK
4 shared publicationsWei Yang
Division of Basic Medicine, Shantou University Medical College, Shantou, China
4 shared publications
Latest Publications
- Open Access
FHL3 Regulates Vascular Smooth Muscle Cell Phenotypic Switching Through the MRTFB-SRF Signaling Axis
Genome-wide association studies have uncovered many coronary artery disease (CAD) loci, but mechanisms linking risk variants to vascular biology remain unclear. We screen candidate causal CAD genes for regulators of the vascular smooth muscle cell (VSMC) contractile phenotype using a pooled CRISPR–Cas9 knockout library in primary human VSMCs with MYH11 protein levels as the readout. FHL3 (four-and-a-half LIM domains protein 3) emerges as the top repressor of the contractile state. Colocalization analyses in a VSMC biobank and vascular tissues associate a CAD risk allele with reduced FHL3 expression. Biochemical and imaging studies show FHL3 is associated and co-localizes with the transcriptional co-activator MRTFB (myocardin-related transcription factor-B). Functionally, FHL3 overexpression attenuates MRTFB-serum response factor (SRF)-driven induction of contractile markers (MYH11, transgelin), whereas FHL3 knockdown increases their expression in an MRTFB-dependent manner. FHL3 knockdown or MRTFB overexpression reduces VSMC proliferation and migration, and FHL3 overexpression mitigates MRTFB-driven effects on these behaviors. These data identify FHL3 as a regulator of VSMC plasticity that inhibits the contractile phenotype by interfering with MRTFB-SRF signaling, link a CAD-associated genetic signal to the VSMC phenotype, and nominate the FHL3-MRTFB interaction as a potential therapeutic target.
Open AccessFHL3 Regulates Vascular Smooth Muscle Cell Phenotypic Switching Through the MRTFB-SRF Signaling Axis
Genome-wide association studies have uncovered many coronary artery disease (CAD) loci, but mechanisms linking risk variants to vascular biology remain unclear. We screen candidate causal CAD genes for regulators of the vascular smooth muscle cell (VSMC) contractile phenotype using a pooled CRISPR–Cas9 knockout library in primary human VSMCs with MYH11 protein levels as the readout. FHL3 (four-and-a-half LIM domains protein 3) emerges as the top repressor of the contractile state. Colocalization analyses in a VSMC biobank and vascular tissues associate a CAD risk allele with reduced FHL3 expression. Biochemical and imaging studies show FHL3 is associated and co-localizes with the transcriptional co-activator MRTFB (myocardin-related transcription factor-B). Functionally, FHL3 overexpression attenuates MRTFB-serum response factor (SRF)-driven induction of contractile markers (MYH11, transgelin), whereas FHL3 knockdown increases their expression in an MRTFB-dependent manner. FHL3 knockdown or MRTFB overexpression reduces VSMC proliferation and migration, and FHL3 overexpression mitigates MRTFB-driven effects on these behaviors. These data identify FHL3 as a regulator of VSMC plasticity that inhibits the contractile phenotype by interfering with MRTFB-SRF signaling, link a CAD-associated genetic signal to the VSMC phenotype, and nominate the FHL3-MRTFB interaction as a potential therapeutic target.
- 7 July 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (13) , e048290
Multiomic Reference Map of Endothelial Mechanosensitive Pathways Under Athero‐ and Erosion‐Prone Flow
Background: Atherosclerosis develops at arterial sites exposed to disturbed flow, whereas plaque rupture and plaque erosion predominantly occur in regions subjected to elevated flow. The impact of elevated flow on regulation of endothelial gene expression is less well studied; therefore, we undertook a comprehensive analysis of primary human coronary artery endothelial cell gene expression under elevated flow, comparing it to gene expression induced by normal physiological and oscillatory flow. Methods: Analysis of human coronary artery endothelial cell messenger RNA, microRNA and protein expression cultured under oscillatory shear stress, physiological laminar shear stress, and elevated shear stress (ESS) for 72 hours. Identification of changes in RNA isoform expression and proximity of flow‐responsive genes to established coronary artery disease risk loci were also performed. Results: A total of 2175 shear‐regulated genes were identified, with 665 uniquely responsive to ESS. Both ESS and oscillatory shear stress induced significant changes in RNA isoform selection, predicted to affect 848 and 580 genes respectively. Signaling pathways regulating coronary artery disease pathogenesis including Hippo, TGFβ/BMP (transforming growth factor beta/bone morphogenetic protein), and IRF (interferon regulatory factor), showed altered RNA isoform selection, which may influence plaque development and plaque erosion. A total of 65% of linkage disequilibrium‐filtered coronary artery disease‐associated genetic variants contained at least 1 oscillatory shear stress or ESS‐regulated gene within 250 kb. Proteomic analysis identified 289 proteins differentially expressed under oscillatory shear stress and 171 under ESS, with notable discordance between messenger RNA and protein changes observed in 28.7% (oscillatory shear stress versus laminar shear stress) and 16.6% (ESS versus laminar shear stress) genes. Additionally, 40 shear‐responsive microRNAs were identified. Conclusions: Elevated flow elicits a distinct gene expression program in human coronary artery endothelial cells, modulating pathways central to coronary artery disease pathogenesis.
- 7 July 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (13) , e048290
Multiomic Reference Map of Endothelial Mechanosensitive Pathways Under Athero‐ and Erosion‐Prone Flow
Background: Atherosclerosis develops at arterial sites exposed to disturbed flow, whereas plaque rupture and plaque erosion predominantly occur in regions subjected to elevated flow. The impact of elevated flow on regulation of endothelial gene expression is less well studied; therefore, we undertook a comprehensive analysis of primary human coronary artery endothelial cell gene expression under elevated flow, comparing it to gene expression induced by normal physiological and oscillatory flow. Methods: Analysis of human coronary artery endothelial cell messenger RNA, microRNA and protein expression cultured under oscillatory shear stress, physiological laminar shear stress, and elevated shear stress (ESS) for 72 hours. Identification of changes in RNA isoform expression and proximity of flow‐responsive genes to established coronary artery disease risk loci were also performed. Results: A total of 2175 shear‐regulated genes were identified, with 665 uniquely responsive to ESS. Both ESS and oscillatory shear stress induced significant changes in RNA isoform selection, predicted to affect 848 and 580 genes respectively. Signaling pathways regulating coronary artery disease pathogenesis including Hippo, TGFβ/BMP (transforming growth factor beta/bone morphogenetic protein), and IRF (interferon regulatory factor), showed altered RNA isoform selection, which may influence plaque development and plaque erosion. A total of 65% of linkage disequilibrium‐filtered coronary artery disease‐associated genetic variants contained at least 1 oscillatory shear stress or ESS‐regulated gene within 250 kb. Proteomic analysis identified 289 proteins differentially expressed under oscillatory shear stress and 171 under ESS, with notable discordance between messenger RNA and protein changes observed in 28.7% (oscillatory shear stress versus laminar shear stress) and 16.6% (ESS versus laminar shear stress) genes. Additionally, 40 shear‐responsive microRNAs were identified. Conclusions: Elevated flow elicits a distinct gene expression program in human coronary artery endothelial cells, modulating pathways central to coronary artery disease pathogenesis.
- Open Access
- 2 June 2026
- Published by Wiley in The Journal of Physiology
- Vol. 604 (14) , 5874-5891
FURIN induces vascular endothelial cell death and efferocytosis through enzymatic cleavage of thrombospondin‐1
The vascular endothelium regulates molecular and cellular exchanges between the blood and tissues. Endothelial cell dysfunction and death, triggered by cardiovascular risk factors, can result in endothelial leakage, leading to atherosclerosis. Evidence indicates that the proprotein convertase FURIN can modulate endothelial cell behaviour and promote atherosclerosis. In this study, we investigated the underlying mechanisms: small interfering RNA (siRNA)‐induced knockdown of FURIN reduced vascular endothelial cell (VEC) apoptosis and efferocytosis by monocyte‐derived macrophages, whereas lentivirus‐mediated overexpression of FURIN had the opposite effect. A co‐immunoprecipitation assay and western blot analyses indicated that FURIN interacted with thrombospondin‐1 (THBS1). Furthermore quantitative RT‐PCR assays and western blot analyses showed that FURIN knockdown resulted in a decrease in THBS1 mRNA and protein levels, whereas THBS1 knockdown attenuated FURIN expression, and these reciprocal regulatory effects were augmented in the presence of LY2109761, an inhibitor of transforming growth factor‐β receptors. THBS1 knockdown largely abolished the influence of FURIN on VEC apoptosis and efferocytosis. Further assays indicated that FURIN knockdown enhanced the integrity and reduced the permeability of a monolayer of cultured VECs, which was counteracted by overexpression of THBS1. In a mouse model of atherosclerosis treatment with a FURIN inhibitor decreased VEC apoptosis in atherosclerotic lesions. Overall these results indicate that by cleaving THBS1 and suppressing THBS1 expression FURIN promotes VEC apoptosis and efferocytosis, leading to increased endothelial permeability. These findings provide a new insight into endothelial dysfunction, with atherogenic relevance and potential therapeutic implications. image Key points: Endothelial dysfunction and cell death may lead to endothelial leakage, triggering atherosclerosis. The proprotein convertase FURIN regulates endothelial cell behaviour and promotes atherosclerosis, but its specific mechanisms remain unclear. This study identifies thrombospondin‐1 (THBS1) as a novel substrate of FURIN in vascular endothelial cells. FURIN binds to and cleaves THBS1, thereby promoting endothelial apoptosis and efferocytosis, increasing endothelial permeability and impairing vascular homeostasis. These findings provide new insights into endothelial dysfunction with atherogenic and therapeutic relevance.
- 2 June 2026
- Published by Wiley in The Journal of Physiology
- Vol. 604 (14) , 5874-5891
Open AccessFURIN induces vascular endothelial cell death and efferocytosis through enzymatic cleavage of thrombospondin‐1
The vascular endothelium regulates molecular and cellular exchanges between the blood and tissues. Endothelial cell dysfunction and death, triggered by cardiovascular risk factors, can result in endothelial leakage, leading to atherosclerosis. Evidence indicates that the proprotein convertase FURIN can modulate endothelial cell behaviour and promote atherosclerosis. In this study, we investigated the underlying mechanisms: small interfering RNA (siRNA)‐induced knockdown of FURIN reduced vascular endothelial cell (VEC) apoptosis and efferocytosis by monocyte‐derived macrophages, whereas lentivirus‐mediated overexpression of FURIN had the opposite effect. A co‐immunoprecipitation assay and western blot analyses indicated that FURIN interacted with thrombospondin‐1 (THBS1). Furthermore quantitative RT‐PCR assays and western blot analyses showed that FURIN knockdown resulted in a decrease in THBS1 mRNA and protein levels, whereas THBS1 knockdown attenuated FURIN expression, and these reciprocal regulatory effects were augmented in the presence of LY2109761, an inhibitor of transforming growth factor‐β receptors. THBS1 knockdown largely abolished the influence of FURIN on VEC apoptosis and efferocytosis. Further assays indicated that FURIN knockdown enhanced the integrity and reduced the permeability of a monolayer of cultured VECs, which was counteracted by overexpression of THBS1. In a mouse model of atherosclerosis treatment with a FURIN inhibitor decreased VEC apoptosis in atherosclerotic lesions. Overall these results indicate that by cleaving THBS1 and suppressing THBS1 expression FURIN promotes VEC apoptosis and efferocytosis, leading to increased endothelial permeability. These findings provide a new insight into endothelial dysfunction, with atherogenic relevance and potential therapeutic implications. image Key points: Endothelial dysfunction and cell death may lead to endothelial leakage, triggering atherosclerosis. The proprotein convertase FURIN regulates endothelial cell behaviour and promotes atherosclerosis, but its specific mechanisms remain unclear. This study identifies thrombospondin‐1 (THBS1) as a novel substrate of FURIN in vascular endothelial cells. FURIN binds to and cleaves THBS1, thereby promoting endothelial apoptosis and efferocytosis, increasing endothelial permeability and impairing vascular homeostasis. These findings provide new insights into endothelial dysfunction with atherogenic and therapeutic relevance.
- Open Access
- 11 February 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
RNA editing in cardiovascular health and disease
Post-transcriptional RNA modifications can alter RNA structure, stability, localization, and function. Adenosine-to-inosine (A-to-I) RNA editing is a post-transcriptional modification that converts adenosine nucleotides in RNA to inosine nucleotides, catalyzed by adenosine-deaminase-acting-on-RNA (ADAR) enzymes. Recent studies have shown that A-to-I RNA editing is required for cardiovascular development and homeostasis whilst aberrant RNA editing plays a role in cardiovascular diseases. This article provides an overview of A-to-I RNA editing events that have been implicated in cardiovascular biology and disease. It also discusses harnessing RNA editing for cardiovascular disease biomarker development and engineering RNA editing for cardiovascular disease treatment.
- 11 February 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessRNA editing in cardiovascular health and disease
Post-transcriptional RNA modifications can alter RNA structure, stability, localization, and function. Adenosine-to-inosine (A-to-I) RNA editing is a post-transcriptional modification that converts adenosine nucleotides in RNA to inosine nucleotides, catalyzed by adenosine-deaminase-acting-on-RNA (ADAR) enzymes. Recent studies have shown that A-to-I RNA editing is required for cardiovascular development and homeostasis whilst aberrant RNA editing plays a role in cardiovascular diseases. This article provides an overview of A-to-I RNA editing events that have been implicated in cardiovascular biology and disease. It also discusses harnessing RNA editing for cardiovascular disease biomarker development and engineering RNA editing for cardiovascular disease treatment.
- Open Access
- 5 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Integrative functional genomics analysis identifies pleiotropic genes for vascular diseases
Several vascular diseases including coronary artery disease, hypertension, stroke, and abdominal aortic aneurysm, have significant genetic underpinnings. Genome-wide association studies have unveiled many genetic loci associated with one or more of these diseases. However, the causative genes at most of these loci are yet to be determined, which hampers the translation of the genetic findings into a better understanding of the disease mechanisms and the identification of new therapeutic targets. Here, in an integrative functional genomics analysis of these loci, we identify a panel of likely causal genes, some of which are pleiotropic for more than one of these vascular diseases. Pooled CRISPR knockout screen analyses of these likely causal genes indicate that many of them influence vascular smooth muscle cell behaviour, and validation experiments of selected genes confirm that FES , BCAR1, CARF and SMARCA4 exert such effects. Further functional experiments focusing on FES , a pleiotropic gene for both coronary artery disease and hypertension, show that it modulates the expression of genes involved in vascular remodeling and that Fes knockout in mice promotes atherosclerosis as well as raises blood pressure. These findings provide an insight into the genetic basis of vascular diseases and inform targets for therapeutic development.
- 5 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessIntegrative functional genomics analysis identifies pleiotropic genes for vascular diseases
Several vascular diseases including coronary artery disease, hypertension, stroke, and abdominal aortic aneurysm, have significant genetic underpinnings. Genome-wide association studies have unveiled many genetic loci associated with one or more of these diseases. However, the causative genes at most of these loci are yet to be determined, which hampers the translation of the genetic findings into a better understanding of the disease mechanisms and the identification of new therapeutic targets. Here, in an integrative functional genomics analysis of these loci, we identify a panel of likely causal genes, some of which are pleiotropic for more than one of these vascular diseases. Pooled CRISPR knockout screen analyses of these likely causal genes indicate that many of them influence vascular smooth muscle cell behaviour, and validation experiments of selected genes confirm that FES , BCAR1, CARF and SMARCA4 exert such effects. Further functional experiments focusing on FES , a pleiotropic gene for both coronary artery disease and hypertension, show that it modulates the expression of genes involved in vascular remodeling and that Fes knockout in mice promotes atherosclerosis as well as raises blood pressure. These findings provide an insight into the genetic basis of vascular diseases and inform targets for therapeutic development.
- Open Access
Dissecting the Cellular Genetics of Cardiovascular Disease Through Endothelial and Immune Compartments Profiling
Background: Non-communicable diseases such as coronary artery disease, atrial fibrillation, type 2 diabetes, hypertension, and others share endothelial dysfunction as one of their underlying features. The endothelium, as the interface between blood and vasculature, shapes disease onset and progression through its response to environmental cues. However, while the genetic component of these diseases has been captured by genome wide association studies (GWAS), which also highlighted a shared immune component, it remains unclear which of these disease loci exerts their effects through endothelial cells. This study identifies, and quantifies, the genetic determinants of endothelial cells molecular traits and their overlap to the common genetic variation component of these diseases. Methods: We generated genotype, RNA-sequencing, H3K27ac ChIP-sequencing, ATAC-sequencing, and endothelial cells barrier stimuli response measurements for 100 samples of human umbilical vein endothelial cells. These were used to identify quantitative trait loci (QTL) for gene expression, transcriptional isoform usage, splice junction usage, chromatin activity and barrier response. We applied statistical colocalisation to identify the overlap between data layers, and to explain molecular QTLs contribution to GWAS disease loci. Results: We used molecular QTLs to identify the regulatory features of 8,214 genes, representing 36% of all expressed genes in endothelial cells. We also identified the molecular mechanisms underlying 815 loci across 16 disease GWAS. These represent between 29% and 40% of all loci for each disease, compared to the previous average of 23%. This is due to the choice of a cell type often underrepresented in tissue level data, and the inclusion of isoform, splicing and chromatin activity datasets. Furthermore, we compared the endothelial cells molecular QTLs with similar datasets in monocytes, neutrophils and CD4 T lymphocytes to shed light on the interplay between the endothelial and the immune compartments in these diseases. We identified loci acting through both the endothelial and the immune compartment, mostly with the same directionality of effect, and endothelial specific ones. Conclusions: This work expands the knowledge of the mechanisms and genes underlying the effect of common genetic variation on non-communicable diseases having endothelial dysfunction as a shared feature. It also illustrates the interplay between endothelial cells and immune cell types in these diseases, highlighting shared and unique pathways.
Open AccessDissecting the Cellular Genetics of Cardiovascular Disease Through Endothelial and Immune Compartments Profiling
Background: Non-communicable diseases such as coronary artery disease, atrial fibrillation, type 2 diabetes, hypertension, and others share endothelial dysfunction as one of their underlying features. The endothelium, as the interface between blood and vasculature, shapes disease onset and progression through its response to environmental cues. However, while the genetic component of these diseases has been captured by genome wide association studies (GWAS), which also highlighted a shared immune component, it remains unclear which of these disease loci exerts their effects through endothelial cells. This study identifies, and quantifies, the genetic determinants of endothelial cells molecular traits and their overlap to the common genetic variation component of these diseases. Methods: We generated genotype, RNA-sequencing, H3K27ac ChIP-sequencing, ATAC-sequencing, and endothelial cells barrier stimuli response measurements for 100 samples of human umbilical vein endothelial cells. These were used to identify quantitative trait loci (QTL) for gene expression, transcriptional isoform usage, splice junction usage, chromatin activity and barrier response. We applied statistical colocalisation to identify the overlap between data layers, and to explain molecular QTLs contribution to GWAS disease loci. Results: We used molecular QTLs to identify the regulatory features of 8,214 genes, representing 36% of all expressed genes in endothelial cells. We also identified the molecular mechanisms underlying 815 loci across 16 disease GWAS. These represent between 29% and 40% of all loci for each disease, compared to the previous average of 23%. This is due to the choice of a cell type often underrepresented in tissue level data, and the inclusion of isoform, splicing and chromatin activity datasets. Furthermore, we compared the endothelial cells molecular QTLs with similar datasets in monocytes, neutrophils and CD4 T lymphocytes to shed light on the interplay between the endothelial and the immune compartments in these diseases. We identified loci acting through both the endothelial and the immune compartment, mostly with the same directionality of effect, and endothelial specific ones. Conclusions: This work expands the knowledge of the mechanisms and genes underlying the effect of common genetic variation on non-communicable diseases having endothelial dysfunction as a shared feature. It also illustrates the interplay between endothelial cells and immune cell types in these diseases, highlighting shared and unique pathways.
- Open Access
Oscillatory and elevated flow distinctly regulate gene expression in human coronary artery endothelial cells
Background: Atherosclerosis develops at arterial sites exposed to disturbed flow, while plaque rupture and plaque erosion predominantly occur in regions subjected to elevated flow. The impact of elevated flow on regulation of endothelial gene expression is less well studied; therefore, we undertook a comprehensive analysis of primary human coronary artery endothelial cell (HCAEC) gene expression under elevated flow, comparing it to gene expression induced by normal physiological and oscillatory flow. Methods: Analysis of HCAEC mRNA, microRNA and protein expression cultured under oscillatory shear stress (OSS), physiological laminar shear stress (LSS), and elevated shear stress (ESS) for 72 hours. Identification of changes in RNA isoform expression and proximity of flow-responsive genes to established coronary artery disease (CAD) risk loci were also performed. Results: 2,175 shear-regulated genes were identified, with 665 uniquely responsive to ESS. Both ESS and OSS induced significant changes in RNA isoform selection, predicted to affect 848 and 580 genes respectively. Signalling pathways regulating CAD pathogenesis including HIPPO, TGFβ/BMP, and IRF, showed altered RNA isoform selection which may influence plaque development and plaque erosion. 65% of linkage disequilibrium (LD)-filtered CAD-associated genetic variants contained at least one OSS or ESS-regulated gene within 250Kb. Proteomic analysis identified 289 proteins differentially expressed under OSS and 171 under ESS, with notable discordance between mRNA and protein changes observed in 28.7% (OSS vs LSS) and 16.6% (ESS vs LSS) genes. Additionally, 40 shear-responsive microRNAs were identified. Conclusion: Elevated flow elicits a distinct gene expression programme in HCAECs, modulating pathways central to CAD pathogenesis. Research Perspective: What New Question Does This Study Raise? Plaque erosion predominantly occurs on the upstream surface of the plaque, where the endothelium is exposed to elevated flow, which we show within this study to evoke a significant and largely unique regulation of the transcriptome, miRome and proteome within primary human coronary artery endothelial cells. Identify shear stress as a significant regulator of alternative splicing, with elevated flow causing the greatest shift in alternative transcript selection. Identify 135 oscillatory, and 101 elevated differentially expressed genes in proximity to CAD risk loci. What Question Should be Addressed Next? Study of the response of the coronary endothelium directly in patients to understand how the risk factors involved in plaque erosion change endothelial function. Creation of physiological 3D arterial models replicating in vivo observations to study the precipitating factors involved in plaque erosion.
Open AccessOscillatory and elevated flow distinctly regulate gene expression in human coronary artery endothelial cells
Background: Atherosclerosis develops at arterial sites exposed to disturbed flow, while plaque rupture and plaque erosion predominantly occur in regions subjected to elevated flow. The impact of elevated flow on regulation of endothelial gene expression is less well studied; therefore, we undertook a comprehensive analysis of primary human coronary artery endothelial cell (HCAEC) gene expression under elevated flow, comparing it to gene expression induced by normal physiological and oscillatory flow. Methods: Analysis of HCAEC mRNA, microRNA and protein expression cultured under oscillatory shear stress (OSS), physiological laminar shear stress (LSS), and elevated shear stress (ESS) for 72 hours. Identification of changes in RNA isoform expression and proximity of flow-responsive genes to established coronary artery disease (CAD) risk loci were also performed. Results: 2,175 shear-regulated genes were identified, with 665 uniquely responsive to ESS. Both ESS and OSS induced significant changes in RNA isoform selection, predicted to affect 848 and 580 genes respectively. Signalling pathways regulating CAD pathogenesis including HIPPO, TGFβ/BMP, and IRF, showed altered RNA isoform selection which may influence plaque development and plaque erosion. 65% of linkage disequilibrium (LD)-filtered CAD-associated genetic variants contained at least one OSS or ESS-regulated gene within 250Kb. Proteomic analysis identified 289 proteins differentially expressed under OSS and 171 under ESS, with notable discordance between mRNA and protein changes observed in 28.7% (OSS vs LSS) and 16.6% (ESS vs LSS) genes. Additionally, 40 shear-responsive microRNAs were identified. Conclusion: Elevated flow elicits a distinct gene expression programme in HCAECs, modulating pathways central to CAD pathogenesis. Research Perspective: What New Question Does This Study Raise? Plaque erosion predominantly occurs on the upstream surface of the plaque, where the endothelium is exposed to elevated flow, which we show within this study to evoke a significant and largely unique regulation of the transcriptome, miRome and proteome within primary human coronary artery endothelial cells. Identify shear stress as a significant regulator of alternative splicing, with elevated flow causing the greatest shift in alternative transcript selection. Identify 135 oscillatory, and 101 elevated differentially expressed genes in proximity to CAD risk loci. What Question Should be Addressed Next? Study of the response of the coronary endothelium directly in patients to understand how the risk factors involved in plaque erosion change endothelial function. Creation of physiological 3D arterial models replicating in vivo observations to study the precipitating factors involved in plaque erosion.
- Open Access
- 8 June 2024
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (6) , 1-12
Genetic influence on vascular smooth muscle cell apoptosis
Vascular smooth muscle cell (VSMC) proliferation, migration, and apoptosis play important roles in many physiological processes and pathological conditions. To identify genetic influences on VSMC behavior, we measured these traits and undertook genome-wide association studies in primary umbilical artery-derived VSMCs from >2000 individuals. Although there were no genome-wide significant associations for VSMC proliferation or migration, genetic variants at two genomic loci (7p15.3 and 7q32.3) showed highly significant associations with VSMC apoptosis (P = 1.95 × 10−13 and P = 7.47 × 10−9, respectively). The lead variant at the 7p51.3 locus was associated with increased expression of the GSDME and PALS2 genes in VSMCs. Knockdown of GSDME or PALS2 in VSMCs attenuated apoptotic cell death. A protein co-immunoprecipitation assay indicated that GSDME complexed with PALS2. PALS2 knockdown attenuated activated caspase-3 and GSDME fragmentation, whilst GSDME knockdown also reduced activated caspase-3. These findings provide new insights into the genetic regulation of VSMC apoptosis, with potential utility for therapeutic development.
- 8 June 2024
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (6) , 1-12
Open AccessGenetic influence on vascular smooth muscle cell apoptosis
Vascular smooth muscle cell (VSMC) proliferation, migration, and apoptosis play important roles in many physiological processes and pathological conditions. To identify genetic influences on VSMC behavior, we measured these traits and undertook genome-wide association studies in primary umbilical artery-derived VSMCs from >2000 individuals. Although there were no genome-wide significant associations for VSMC proliferation or migration, genetic variants at two genomic loci (7p15.3 and 7q32.3) showed highly significant associations with VSMC apoptosis (P = 1.95 × 10−13 and P = 7.47 × 10−9, respectively). The lead variant at the 7p51.3 locus was associated with increased expression of the GSDME and PALS2 genes in VSMCs. Knockdown of GSDME or PALS2 in VSMCs attenuated apoptotic cell death. A protein co-immunoprecipitation assay indicated that GSDME complexed with PALS2. PALS2 knockdown attenuated activated caspase-3 and GSDME fragmentation, whilst GSDME knockdown also reduced activated caspase-3. These findings provide new insights into the genetic regulation of VSMC apoptosis, with potential utility for therapeutic development.
- Top Cited PapersOpen Access
- 17 October 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (20) , e031121
Phenotypic Switching of Vascular Smooth Muscle Cells in Atherosclerosis
The medial layer of the arterial wall is composed mainly of vascular smooth muscle cells (VSMCs). Under physiological conditions, VSMCs assume a contractile phenotype, and their primary function is to regulate vascular tone. In contrast with terminally differentiated cells, VSMCs possess phenotypic plasticity, capable of transitioning into other cellular phenotypes in response to changes in the vascular environment. Recent research has shown that VSMC phenotypic switching participates in the pathogenesis of atherosclerosis, where the various types of dedifferentiated VSMCs accumulate in the atherosclerotic lesion and participate in the associated vascular remodeling by secreting extracellular matrix proteins and proteases. This review article discusses the 9 VSMC phenotypes that have been reported in atherosclerotic lesions and classifies them into differentiated VSMCs, intermediately dedifferentiated VSMCs, and dedifferentiated VSMCs. It also provides an overview of several methodologies that have been developed for studying VSMC phenotypic switching and discusses their respective advantages and limitations.
- 17 October 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (20) , e031121
Top Cited PapersOpen AccessPhenotypic Switching of Vascular Smooth Muscle Cells in Atherosclerosis
The medial layer of the arterial wall is composed mainly of vascular smooth muscle cells (VSMCs). Under physiological conditions, VSMCs assume a contractile phenotype, and their primary function is to regulate vascular tone. In contrast with terminally differentiated cells, VSMCs possess phenotypic plasticity, capable of transitioning into other cellular phenotypes in response to changes in the vascular environment. Recent research has shown that VSMC phenotypic switching participates in the pathogenesis of atherosclerosis, where the various types of dedifferentiated VSMCs accumulate in the atherosclerotic lesion and participate in the associated vascular remodeling by secreting extracellular matrix proteins and proteases. This review article discusses the 9 VSMC phenotypes that have been reported in atherosclerotic lesions and classifies them into differentiated VSMCs, intermediately dedifferentiated VSMCs, and dedifferentiated VSMCs. It also provides an overview of several methodologies that have been developed for studying VSMC phenotypic switching and discusses their respective advantages and limitations.
- Open Access
Allele-Specific Epigenetic Regulation of FURIN Expression at a Coronary Artery Disease Susceptibility Locus
Genome-wide association studies have revealed an association between the genetic variant rs17514846 in the FURIN gene and coronary artery disease. We investigated the mechanism through which rs17514846 modulates FURIN expression. An analysis of isogenic monocytic cell lines showed that the cells of the rs17514846 A/A genotype expressed higher levels of FURIN than cells of the C/C genotype. Pyrosequencing showed that the cytosine (in a CpG motif) at the rs17514846 position on the C allele was methylated. Treatment with the DNA methylation inhibitor 5-aza-2′-deoxycytidine increased FURIN expression. An electrophoretic mobility super-shift assay with a probe corresponding to the DNA sequence at and around the rs17514846 position of the C allele detected DNA-protein complex bands that were altered by an anti-MeCP2 antibody. A chromatin immunoprecipitation assay with the anti-MeCP2 antibody showed an enrichment of the DNA sequence containing the rs17514846 site. siRNA-mediated knockdown of MeCP2 caused an increase in FURIN expression. Furthermore, MeCP2 knockdown increased monocyte migration and proliferation, and this effect was diminished by a FURIN inhibitor. The results of our study suggest that DNA methylation inhibits FURIN expression and that the coronary artery disease-predisposing variant rs17514846 modulates FURIN expression and monocyte migration via an allele-specific effect on DNA methylation.
Open AccessAllele-Specific Epigenetic Regulation of FURIN Expression at a Coronary Artery Disease Susceptibility Locus
Genome-wide association studies have revealed an association between the genetic variant rs17514846 in the FURIN gene and coronary artery disease. We investigated the mechanism through which rs17514846 modulates FURIN expression. An analysis of isogenic monocytic cell lines showed that the cells of the rs17514846 A/A genotype expressed higher levels of FURIN than cells of the C/C genotype. Pyrosequencing showed that the cytosine (in a CpG motif) at the rs17514846 position on the C allele was methylated. Treatment with the DNA methylation inhibitor 5-aza-2′-deoxycytidine increased FURIN expression. An electrophoretic mobility super-shift assay with a probe corresponding to the DNA sequence at and around the rs17514846 position of the C allele detected DNA-protein complex bands that were altered by an anti-MeCP2 antibody. A chromatin immunoprecipitation assay with the anti-MeCP2 antibody showed an enrichment of the DNA sequence containing the rs17514846 site. siRNA-mediated knockdown of MeCP2 caused an increase in FURIN expression. Furthermore, MeCP2 knockdown increased monocyte migration and proliferation, and this effect was diminished by a FURIN inhibitor. The results of our study suggest that DNA methylation inhibits FURIN expression and that the coronary artery disease-predisposing variant rs17514846 modulates FURIN expression and monocyte migration via an allele-specific effect on DNA methylation.